OXFORD CANNABINOID TECHNOLOGIES HOLDINGS PLC

Highlights Oxford Cannabinoid Technologies Holdings Plc

Equities

OCTP

GB00BMVMRB86

Delayed London S.E. Other stock markets 01:45:31 13/05/2024 pm IST			5-day change	1st Jan Change
0.13 ^GBX	-13.33%		-59.43%	-77.28%

08/05	Oxford Cannabinoid shares plummet following delisting request	AN
08/05	Oxford Cannabinoid Technologies Files for Delisting From London Bourse	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Oxford Cannabinoid Technologies Files for Delisting From London Bourse	08/05	MT
Oxford Cannabinoid teams with iNGENu to test OCT130401 pain treatment	11/04	AN
Oxford Cannabinoid completes capital reorganisation	16/02	AN
Oxford Cannabinoid shares up on applying to admit new shares	15/02	AN
Oxford Cannabinoid applies for new shares to be listed	15/02	AN
Oxford Cannabinoid Technologies Enters Convertible Loan Note Agreements	02/02	MT
Oxford Cannabinoid agrees GBP565,000 loan notes deal	02/02	AN
Oxford Cannabinoid Technologies down after GBP1.2 million fundraise	30/01	AN
Oxford Cannabinoid Technologies Holdings Plc Reports Earnings Results for the Half Year Ended October 31, 2023	30/01	CI
Oxford Cannabinoid Technologies Files Patent for New Cannabinoid Compound in Europe	10/01	MT
Oxford Cannabinoid stock goes high on Europe patent filing	10/01	AN
Oxford Cannabinoid Technologies Holdings plc Files A European Application in Own Name, Directed to Programme 2	10/01	CI
Oxford Cannabinoid Technologies Holdings plc Announces Phase I Clinical Trial Results for Lead Drug Candidate OCT461201	10/23/10	CI
Oxford Cannabinoid Technologies Holdings plc Announces Final Dose Administered in Phase I Clinical Trial	25/23/25	CI
Gulf Keystone swings to loss; Gulf Marine optimistic	31/23/31	AN
Earnings Flash (OCTP.L) OXFORD CANNABINOID TECH.HOLDINGS Reports FY23 Loss GBX-0.62	31/23/31	MT
Oxford Cannabinoid Technologies Holdings Plc Reports Earnings Results for the Full Year Ended April 30, 2023	31/23/31	CI
Pod Point cuts outlook; CVS Group buys in Australia	27/23/27	AN
Oxford Cannabinoid Technologies Holdings plc Announces Expansion into Oncology Potential New Cannabinoid-Based Treatment of Cancer Malignancies	17/23/17	CI
Oxford Cannabinoid Technologies Holdings plc Announces Mhra and Rec 2 Approval of Phase I Clinical Trial Application	17/23/17	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Oxford Cannabinoid Technologies Holdings Plc

Equities

OCTP

GB00BMVMRB86

Highlights

Filters